Expression of Fas ligand and Caspase-3 contributes to formation of immune escape in gastric cancer

World Journal of Gastroenterology

Volumn 9, Issue 7, 2003, Pages 1415-1420

  Zheng, Hua Chuan ^a   Sun, Jin Min ^a   Wei, Zheng Li ^a   Yang, Xue Fei ^a   Zhang, Yin Chang ^a   Xin, Yan ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; CASPASE 3; FAS LIGAND; PEROXIDASE; STREPTAVIDIN;

ADOLESCENT; ADULT; AGED; APOPTOSIS; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INVASION; CARCINOGENESIS; CHI SQUARE TEST; CHILD; CLINICAL FEATURE; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LYMPHOCYTE; LYMPHOCYTIC INFILTRATION; MAJOR CLINICAL STUDY; MALE; METASTASIS; MOLECULAR MECHANICS; PATHOLOGY; PROTEIN EXPRESSION; STOMACH CANCER; TUMOR DIFFERENTIATION; TUMOR VOLUME; UPREGULATION;

EID: 0043066733     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v9.i7.1415     Document Type: Article

References (33)

1. Zhou YN, Xu CP, Han B, Li M, Qiao L, Fang DC, Yang JM. Expression of E-cadherin and beta-catenin in gastric carcinoma and its correlation with the clinicopathological features and patient survival. World J Gastroenterol 2002; 8: 987-993
2. Fang DC, Luo YH, Yang SM, Li XA, Ling XL, Fang L. Mutation analysis of APC gene in gastric cancer with microsatellite instability. World J Gastroenterol 2002; 8: 787-791
3. Song ZJ, Gong P, Wu YE. Relationship between the expression of iNOS, VEGF, tumor angiogenesis and gastric cancer. World J Gastroenterol 2002; 8: 591-595
4. Yao XX, Yin L, Sun ZC. The expression of hTERT mRNA and cellular immunity in gastric cancer and precancerosis. World J Gastroenterol 2002; 8: 586-590
5. Niu WX, Qin XY, Liu H, Wang CP. Clinicopathological analysis of patients with gastric cancer in 1200 cases. World J Gastroenterol 2001; 7: 281-284
6. Xin Y, Li XL, Wang YP, Zhang SM, Zheng HC, Wu DY, Zhang YC. Relationship between phenotypes of cell-function differentiation and pathobiological behavior of gastric carcinomas. World J Gastroenterol 2001; 7: 53-59
7. Jiang BJ, Sun RX, Lin H, Gao YF. Study on the risk factors of lymphatic metastasis and the indications of less invasive operations in early gastric cancer. World J Gastroenterol 2000; 6: 553-556
8. Jemal A, Thomas A, Murray T, Thun M.R. Cancer statistics, 2002. CA Cancer J Clin 2002; 52: 23-47
9. Theuer CP. Asian gastric cancer patients at a southern California comprehensive cancer center and diagnosed with less advanced disease and have superior stage-stratified survival. Am Surg 2000; 66: 821-826
10. Schmidt PH, Lee JR, Joshi V, Playford RJ, Poulsom R, Wright NA, Goldenring JR. Identification of a metaplastic cell lineage associated with human gastric adenocarcinoma. Lab Invest 1999; 79: 639-646
11. Bajtai A, Hidvegi J. The role of gastric mucosal dysplasia in the development of gastric carcinoma. Pathol Oncol Res 1998; 4: 297-300
12. Sakata K, Sakata A, Kong L, Dang H, Talal N. Role of Fas/FasL interaction in physiology and pathology: The good and the bad. Clin Immunol Immunopathol 1998; 87: 1-7
13. O'Connell J, Bennett MW, O'Sullivan GC, Roche D, Kelly J, Kelly J, Collins JK, Shanahan F. Fas ligand expression in primary colon adenocarcinomas: Evidence that the Fas counterattack is a prevalent mechanism of immune evasion in human colon cancer. J Pathol 1998; 186: 240-246
14. Mitsiades N, Yu WH, Poulaki V, Tsokos M, Stamenkovic I. Matrix metalloproteinase-7-mediated cleavage of Fas ligand protects tumor cells from chemotherapeutic drug cytotoxicity. Cancer Res 2001; 61: 577-581
15. Wilson MR. Apoptosis: Unmasking the executioner. Cell Death Differ 1998; 5: 646-652
16. Slee EA, Adrain C, Martin SJ. Serial killers: Ordering caspase activation events in apoptosis. Cell Death Differ 1999; 6: 1067-1074
17. Porter AG, Janicke RU. Emerging roles of caspase-3 in apoptosis. Cell Death Differ 1999; 6: 99-104
18. Shaham S, Reddien PW, Davies B, Horvitz HR. Mutational analysis of the Caenorhabditis elegans cell-death gene ced-3. Genetics 1999; 153: 1655-1671
19. Tian R, Zhang GY, Yan CH, Dai YR. Involvement of poly (ADP-ribose) polymerase and activation of caspase-3-like protease in heat shock-induced apoptosis in tobacco suspension cells. FEBS Lett 2000; 474: 11-15
20. Kutsyi MP, Kuznetsova EA, Gaziev AI. Involvement of proteases in apoptosis. Biochemistry (Mosc) 1999; 64: 115-126
21. Truong-Tran AQ, Carter J, Ruffin RE, Zalewski PD. The role of zinc in caspase activation and apoptotic cell death. Biometals 2001; 14: 315-330
22. Fujii Y, Matsura T, Kai M, Matsui H, Kawasaki H, Yamada K. Mitochondrial cytochrome c release and caspase-3-like protease activation during indomethacin-induced apoptosis in rat gastric mucosal cells. Proc Soc Exp Biol Med 2000; 224: 102-108
23. Umeda T, Kouchi Z, Kawahara H, Tomioka S, Sasagawa N, Maeda T, Sorimachi H, Ishiura S, Suzuki K. Limited proteolysis of filamin is catalyzed by caspase-3 in U937 and Jurkat cells. J Biochem (Tokyo) 2001; 130: 535-542
24. Li H, Liu N, Guo L, Li JW, Liu JR. Frequent expression of soluble Fas and Fas ligand in Chinese stomach cancer and its preneoplastic lesions. Int J Mol Med 2000; 5: 473-476
25. Chang HY, Yang X. Proteases for cell suicide: Functions and regulation of caspases. Microbiol Mol Biol Rev 2000; 64: 821-846
26. O'Connell J, Bennett MW, Nally K, Houston A, O'Sullivan GC, Shanahan F. Altered mechanisms of apoptosis in colon cancer: Fas resistance and counterattack in the tumor-immune conflict. Ann N Y Acad Sci 2000; 910: 178-192
27. Izban KF, Wrone-Smith T, Hsi ED, Schnitzer B, Quevedo ME, Alkan S. Characterization of the interleukin-1beta-converting enzyme/ced-3-family protease, caspase-3/CPP32, in Hodgkin's disease: Lack of caspase-3 expression in nodular lymphocyte predominance Hodgkin's disease. Am J Pathol 1999; 154: 1439-1447
28. Belluco C, Esposito G, Bertorelle R, Alaggio R, Giacomelli L, Bianchi LC, Nitti D, Lise M. Fas ligand is up-regulated during the colorectal adenoma-carcinoma sequence. Eur J Surg Oncol 2002; 28: 120-125
29. Bennett MW, O'Connell J, Houston A, Kelly J, O'Sullivan GC, Collins JK, Shanahan F. Fas ligand upregulation is an early event in colonic carcinogenesis. J Clin Pathol 2001; 54: 598-604
30. Hoshi T, Sasano H, Kato K, Yabuki N, Ohara S, Konno R, Asaki S, Toyota T, Tateno H, Nagura H. Immunohistochemistry of Caspase3/CPP32 in human stomach and its correlation with cell proliferation and apoptosis. Anticancer Res 1998; 18: 4347-4353
31. Bennett MW, O'Connell J, O'Sullivan GC, Brady C, Roche D, Collins JK, Shanahan F. The Fas counterattack in vivo: Apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma. J Immunol 1998; 160: 5669-5675
32. Tsutsumi S, Kuwano H, Shimura T, Morinaga N, Mochiki E, Asao T. Circulating soluble Fas ligand in patients with gastric carcinoma. Cancer 2000; 89: 2560-2564
33. Torosian MH, Bartlett DL. Inhibition of tumor metastasis by a circulating suppressor factor. J Surg Res 1993; 55: 74-79